Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Register entry · Assessment Committee

Dr Wilhelmina Achebe-Sørensen

Assessment Committee member, methods. Senior Research Fellow, evidence synthesis

Document identifier
CEI-RG-019
Series
Register entry
Version
1.0
Published
15 Jan 2024
Last reviewed
30 Jul 2026
Certainty
Not rated

§1Register entry

§1.1Register entry

Name
Dr Wilhelmina Achebe-Sørensen
Credentials
PharmD, MSc (Health Economics)
Role
Assessment Committee member, methods
Body
Assessment Committee
Affiliation
Senior Research Fellow, evidence synthesis
Registered since
2024
Specialism
not recorded

§1.2Declared interests

Declared interests are published in full for every register entry. A declaration is not a disqualification, and the Institute has never given a submission or a review less weight on that ground. The materiality threshold and the recusal rules are set out in the conflicts-of-interest policy, which was settled through public consultation.

§1.3Attribution

Members of the board, the assessment committee and the secretariat are named with their role, affiliation and declared interests. The committee ratifies every certainty rating the Institute publishes and is chaired independently of the board.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.